Silver Cross Hospital, Teladoc partner for telehealth

New Lenox, Ill.-based Silver Cross Hospital has partnered with Teladoc to offer patients remote treatment services, according to CBS Chicago. The program is slated to launch Jan. 1, 2017.

Advertisement

Through the Teladoc platform, Silver Cross Hospital patients will be able to access physicians in the company’s network for remote consultations online or over the phone. These physicians can provide care for conditions like allergies, skin rashes and pink eye.

One of the program’s goals is to decongest the hospital’s emergency room, by encouraging patients with minor ailments to receive remote treatment, rather than waiting for unnecessary emergency care. However, if a Teladoc physician determines a patient is in need of an in-person visit, they will be directed to an emergency room, urgent care center or primary care physician.

Ruth Colby, chief strategy officer for Silver Cross Hospital, told CBS Chicago that Teladoc will charge patients $49 for each virtual visit. Insurance coverage will vary by patient plan.

More articles on health IT:
12 healthcare ransomware attacks of 2016
$15k in electronic, computer items stolen from Pennsylvania outpatient hospital
Why the phrase ‘Can I ask you a question?’ drives athenahealth CEO Jonathan Bush nuts

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Released OR time is leaving capacity — and revenue — on the table

Wednesday, July 22
1:00 PM - 2:00 PM CDT

Presenters: Kelly Connolly, MHSA, PMPJane Yang, MHACaity Butler, MSN, RN, CNORThomas Brehmer

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.